Loading
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (4 ops.)
Latest filing published 10 Dec 2015 for Palatin Technologies INC.
Insider track record
Disclosed buys
3
Disclosed sells
4
Signal history
No signal scores available.
Closed purchases
Market purchases
3
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +26.7%Entry US$750.00 · Close at T+365 US$950.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Zola P. Horovitz: trading record in brief
Zola P. Horovitz is a declared insider at 7 companies; the most frequent names are Biocryst Pharmaceuticals Inc, DOV Pharmaceutical Inc and Genvec Inc. In total, 19 filings cover trades dated from 13 March 2006 to 8 December 2015.
Both buying and selling appear: 3 purchases worth €14k, against 4 sales worth €287k. Netting one side against the other leaves €274k of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 6 option exercises.
A typical purchase (the median) is worth €4,552.
On 10 December 2015 came the latest disclosure, a share grant in Palatin Technologies Inc. The latest purchase dates back some time: it was published 5,048 days ago, on 27 December 2012. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Zola P. Horovitz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations19 total
50,000 shares0Common StockSEC:0001354488-15-005495:0
15,000 shares0Common StockSEC:0001354488-15-003162:0
75,000 shares0Common StockSEC:0001140361-13-035110:0
10,000 shares@ US$0.60common stockSEC:0001088020-12-000074:0
Canonical exit: 24 Mar 2013 (T+90)
3,000 shares@ US$2.37Common StockSEC:0001140361-11-042218:0
Canonical exit: 10 Nov 2011 (T+90)
10,000 shares@ US$2.60Common StockSEC:0001127602-10-008867:0
10,000 shares@ US$7.22Common StockSEC:0001127602-10-008867:1
10,000 shares@ US$3.38Common StockSEC:0001127602-10-003255:0
10,000 shares@ US$6.85Common StockSEC:0001127602-10-003255:1
5,000 shares@ US$1.43Common Stock, $0.001 par valueSEC:0000932903-09-000001:0
17,500 sharesCommon StockSEC:0001179110-09-006815:0
5,000 shares@ US$0.72Common StockSEC:0001179110-09-005215:0
10,000 shares@ US$0.50Common StockSEC:0001140361-08-026302:0
Canonical exit: 19 Feb 2009 (T+90)
12,500 shares@ US$0.72Common StockSEC:0001179110-07-006097:0
5,429 sharesCommon Stock (non-vested shares)SEC:0001083132-07-000007:0
5,000 shares@ US$3.25Common Stock, $0.001 par valueSEC:0000932903-07-000010:0
5,000 sharesCommon Stock, par value $0.0001 per shareSEC:0001005477-06-002768:0
12,400 shares@ US$2.78Common Stock, par value $0.0001 per shareSEC:0001005477-06-001739:0
12,400 shares@ US$17.43Common Stock, par value $0.0001 per shareSEC:0001005477-06-001739:1
19 of 19 declarations
